Ilya D Ionov Selected Research

cyclosomatostatin

1/2021	Anticataleptic activity of nicotine in rats: involvement of the lateral entorhinal cortex.
1/2020	Cyclosomatostatin-induced catalepsy in aged rats: Specific change of brain c-Fos protein expression in the lateral entorhinal cortex.
1/2018	Brain sites mediating cyclosomatostatin-induced catalepsy in Wistar rats: A specific role for the nigrostriatal system and locus coeruleus.
1/2018	Cyclosomatostatin- and haloperidol-induced catalepsy in Wistar rats: Differential responsiveness to sleep deprivation.
1/2013	Somatostatin antagonist induces catalepsy in the aged rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilya D Ionov Research Topics

Disease

11	Catalepsy 01/2022 - 01/2012
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2012
2	Sleep Deprivation 01/2018 - 07/2010
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Depressive Disorder (Melancholia) 01/2021
1	Tremor (Tremors) 01/2020
1	Neoplasms (Cancer) 11/2018
1	Carcinogenesis 11/2018
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2013
1	Paraplegia (Spastic Paraplegia) 04/2012
1	Motor Disorders 04/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2012
1	Muscle Spasticity (Spastic) 04/2012
1	Alzheimer Disease (Alzheimer's Disease) 08/2010
1	Epilepsy (Aura) 10/2009

Drug/Important Bio-Agent (IBA)

5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 12/2012
5	Haloperidol (Haldol)FDA LinkGeneric 01/2022 - 01/2012
5	cyclosomatostatinIBA 01/2021 - 01/2013
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 01/2012
2	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 01/2012
2	Nicotine FDA Link 01/2021 - 11/2019
2	BicucullineIBA 01/2020 - 04/2012
2	Pharmaceutical PreparationsIBA 11/2018 - 12/2012
2	EnkephalinsIBA 08/2010 - 10/2009
1	6- cyclopropylmethyl- 2- (2,4- dichlorophenyl)- 7- ethyl- 4- methyl- 7,8- dihydro- 6H- 1,3,6,8a- tetraazaacenaphthyleneIBA 01/2022
1	Histamine H2 ReceptorsIBA 01/2022
1	CRF receptor type 1IBA 01/2022
1	Ranitidine (Zantac)FDA LinkGeneric 01/2022
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2021
1	Diphenhydramine (Benadryl)FDA LinkGeneric 01/2021
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2020
1	Memantine (Namenda)FDA Link 01/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	RotenoneIBA 11/2019
1	NeurotoxinsIBA 11/2019
1	Imipramine (Janimine)FDA LinkGeneric 11/2019
1	Drug CombinationsIBA 11/2018
1	Thalidomide (Thalomid)FDA Link 11/2018
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018
1	Cetirizine (Zyrtec)FDA LinkGeneric 11/2018
1	Dopamine AntagonistsIBA 01/2018
1	N-Methylaspartate (NMDA)IBA 04/2012
1	gamma-Aminobutyric Acid (GABA)IBA 04/2012
1	Dopamine (Intropin)FDA LinkGeneric 01/2012
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2012
1	Cholinergic Agents (Cholinergics)IBA 08/2010
1	Opioid Analgesics (Opioids)IBA 07/2010
1	volinanserinIBA 07/2010
1	Naloxone (Narcan)FDA LinkGeneric 07/2010
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2009

Therapy/Procedure

2	Injections 01/2020 - 04/2012
1	Therapeutics 01/2022